Sign in for the best experience.
As a CHEST member, you’re part of a strong network of clinicians representing every profession and experience level in chest medicine. With us, you can develop personal and professional connections, cultivate your leadership skills, advocate for policies that improve access to health, and advance your career.
JOIN TODAY ABOUT MEMBERSHIP »
Advertisement
A CHEST research grant made it possible for a team at Johns Hopkins to measure air quality in and around the homes of patients with sarcoidosis in hopes of discovering what role air pollution plays in the disease. Read a recent blog post to hear more about the future of this project with insights from the codirector of the Johns Hopkins Sarcoidosis Center, Michelle Sharp, MD, MHS, FCCP.
READ MORE »
Learn about the hot topics we'll be covering in Phoenix, October 18 to 21, in lung cancer, airways disease, chest infections, lung transplant, and more. Read new blogs from Curriculum Group leads and Network Chairs for insight on the topics you can expect coverage on.
READ MORE»
Review essential leadership competencies and develop an awareness of the attributes of an effective leader, the features of an efficient team, and a useful approach to conflict management. Sign up for a free course happening ahead of CHEST 2026 on Saturday, October 17.
SIGN UP »
Emerging data suggest a potential expanding role for corticosteroids in severe cases of community-acquired pneumonia (CAP), though it remains uncertain whether this approach should extend to nonsevere or outpatient settings. In a new CHEST Physician® article, members of the Chest Infections Section highlight a recent trial evaluating the role of adjunctive corticosteroids in CAP and relevant clinical practice guidelines.
As image-based markers become increasingly integrated into severe asthma phenotyping, the mucus plug score (MPS) may evolve into a clinically actionable tool. In a new CHEST Physician article, members of the Asthma and COPD Section discuss studies and trials that analyzed MPSs to track improvements in FEV1, decreased air trapping, and airway resistance following biological use.
Orexin receptor agonist therapy represents a promising and exciting step toward a precision medicine approach that directly targets the underlying deficiency of orexin signaling in narcolepsy type 1. In a new CHEST Physician article, members of the Nonrespiratory Sleep Section discuss studies into common treatments for excessive daytime sleepiness.
Join the conversation on social media and connect with members of the CHEST community.
Gain experience with bedside critical care ultrasound, airway management, mechanical ventilation, and common ICU procedures, August 6 to 8.
Strengthen your clinical expertise, gain the knowledge needed to succeed on the board exams, and prepare for the Longitudinal Knowledge Assessment.
Gain familiarity with skills including calibration, test setup and performance, quality control measures, test interpretation, and reporting, August 20 to 21.
When you become an FCCP (Fellow of the American College of Chest Physicians), you play an active role in advancing the field of chest medicine while enjoying the prestige of being associated with a distinctive group of chest medicine professionals.
“I have found being an FCCP to be rewarding on a personal level, as well as a professional level. It has provided me with connections to colleagues nationally and internationally, and it has opened the door to leadership opportunities.”
– Thomas Van der Kloot, MD, FCCP
FIND OUT MORE